Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMMP
IMMP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMMP News
Rosen Law Firm Investigates Immutep Securities Claims
1d ago
PRnewswire
Rosen Law Firm Investigates Immutep Securities Claims
2d ago
Globenewswire
Rosen Law Firm Investigates Securities Claims Against Immutep Ltd.
5d ago
Globenewswire
Immutep's Eftilagimod Alfa Receives FDA Orphan Drug Designation
5d ago
NASDAQ.COM
Immutep Receives FDA Orphan Drug Designation
5d ago
Newsfilter
FDA Grants Orphan Drug Designation to Immutep's Eftilagimod Alfa
5d ago
stocktwits
Rosen Law Firm Investigates Immutep Securities Claims
6d ago
PRnewswire
Rosen Law Firm Investigates Immutep Securities Claims
Apr 11 2026
Globenewswire
Rosen Law Firm Investigates Securities Claims Against Immutep Ltd.
Apr 09 2026
PRnewswire
Investigation Launched into Immutep for Securities Fraud Claims
Apr 07 2026
Globenewswire
Investigation of Securities Claims Against Immutep Ltd.
Apr 05 2026
Globenewswire
Rosen Law Firm Investigates Immutep Securities Claims
Apr 04 2026
PRnewswire
Immutep Faces Securities Claims Investigation
Apr 03 2026
Globenewswire
Immutep Under Investigation for Securities Fraud
Apr 02 2026
PRnewswire
Immutep Under Investigation for Possible Securities Fraud
Mar 31 2026
Globenewswire
Rosen Law Firm Investigates Immutep Securities Claims
Mar 30 2026
Globenewswire
Show More News
